A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines-Reference-Cited by-同舟云学术

A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines

Published:2012-08 Issue:36 Volume:30 Page:5302-5304
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Laurens Matthew B.,Duncan Christopher J.,Epstein Judith E.,Hill Adrian V.,Komisar Jack L.,Lyke Kirsten E.,Ockenhouse Christian F.,Richie Thomas L.,Roestenberg Meta,Sauerwein Robert W.,Spring Michele D.,Talley Angela K.,Moorthy Vasee S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference9 articles.

1. Experimental human challenge infections can accelerate clinical malaria vaccine development;Sauerwein;Nat Rev Immunol,2011

2. Protection against a malaria challenge by sporozoite inoculation;Roestenberg;N Engl J Med,2009

3. The RTS,S malaria vaccine;Casares;Vaccine,2010

4. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum;Chulay;Am J Trop Med Hyg,1986

5. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria;Kester;J Infect Dis,2001

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms;Nature Communications;2024-06-18

2. Benefits of Combining Molecular Biology and Controlled Human Infection Model Methodologies in Advancing Vaccine Development;Journal of Molecular Biology;2023-12

3. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial;The Lancet Infectious Diseases;2023-05

4. Controlled Human Infection Models To Accelerate Vaccine Development;Clinical Microbiology Reviews;2022-09-21

5. Five decades of clinical assessment of whole-sporozoite malaria vaccines;Frontiers in Immunology;2022-09-08